Department of Gastrointestinal Oncology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.
Dig Endosc. 2013 May;25 Suppl 2:6-10. doi: 10.1111/den.12114.
Submucosal invasive colorectal cancers (SM-CRC) have approximately a 10% chance of lymph node metastasis, which requires surgical resection including lymph node dissection for curative treatment. It is important to optimally survey patients after curative resection for SM-CRC in order to detect early recurrence. In the present report, we principally show the long-term outcomes after follow up of SM-CRC resected endoscopically based on a report of the literature and our experience in Japan. The long-term outcomes of low-risk SM-CRC endoscopically resected alone or high-risk SM-CRC with additional surgical resection with lymph node dissection are excellent. However, the risk of local recurrence of endoscopic resection alone in patients with high-risk submucosal invasive cancer was significantly higher in rectal cancer as compared to similar colonic cancer. Patients with submucosal rectal cancer showing high-risk pathological features are, therefore, strongly recommended to undergo additional treatment. We consider that longer follow up is required for patients with SM-CRC because recurrence occurred relatively later in SM-CRC compared to advanced colorectal cancer.
黏膜下浸润性结直肠癌(SM-CRC)有 10%左右发生淋巴结转移的风险,需要进行包括淋巴结清扫的手术切除以达到治愈效果。对接受治愈性切除的 SM-CRC 患者进行最佳随访,以早期发现复发,这一点非常重要。本报告主要根据文献报告和我们在日本的经验,展示内镜切除 SM-CRC 后的长期结果。单独内镜切除低危 SM-CRC 或高危 SM-CRC 加淋巴结清扫术的长期结果非常好。然而,与结肠类似肿瘤相比,内镜切除单独治疗高危黏膜下浸润性直肠癌的局部复发风险明显更高。因此,强烈建议具有高危黏膜下直肠肿瘤特征的患者接受额外的治疗。我们认为,由于黏膜下结直肠癌的复发时间相对较晚,因此患者需要进行更长时间的随访。